which is chronic renal failure. The objective of this study was to investigate halitosis levels in end-stage renal disease (ESRD) patients before and after peritoneal dialysis (PD) therapy. ♦ Methods: 42 subjects with ESRD were included in this study. The presence of halitosis was assessed using an organoleptic measurement and compared with blood urea nitrogen (BUN) levels and salivary flow rates. Decayed, missing, and filled teeth (DMFT) index and Community Peri odontal Index (CPI) were calculated. All measurements were done before and after patients had received 3 months of PD therapy. ♦ Results: Mean serum BUN level was found to be lower (46.05 ± 13.30 vs 91.24 ± 31.28 mg/dL), salivary flow rate higher (0.34 ± 0.07 vs 0.26 ± 0.04 mL/mi...
Background/Aims: The main purpose of the present study was to determine the effect of peritoneal cha...
This study aimed to determine the factors that were associated with hypoalbuminemia in peritoneal di...
Peritoneal dialysis (PD) is a well-established modality for treatment of patients with end-stage ren...
Kamal Hassan,1,2 Hassan Fadi3 1Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Isra...
OBJECTIVE: To analyze and compare periodontal parameters in chronic renal failure (CRF) patients und...
Introduction. The effect of serum uric acid (SUA) concentration on residual urine volume in peritone...
to this paper. b Co-corresponding authors. ♦ Background: Endothelial dysfunction, which contributes...
.Objective:To determine the effect of peritoneal dialysis modalities such as nightly intermittent pe...
Background: There is a paucity of information on whether peritoneal dialysis (PD) slows the decline ...
Halitosis is a condition that affects 50% of adults and one third of patients with chronic kidney di...
Aim: To evaluate the oral conditions of patients with chronic kidney disease undergoing dialysis and...
The transport characteristics of the peritoneal membrane may be influenced by inflammation and vario...
Objective. The aim of this study was to investigate oral manifestations and salivary changes in pati...
Background and Aim: Halitosis, candidiasis, and metallic taste are some of the oral complications in...
Saliva plays a major role in preserving the integrity of oral tissues. The oral health of renal fail...
Background/Aims: The main purpose of the present study was to determine the effect of peritoneal cha...
This study aimed to determine the factors that were associated with hypoalbuminemia in peritoneal di...
Peritoneal dialysis (PD) is a well-established modality for treatment of patients with end-stage ren...
Kamal Hassan,1,2 Hassan Fadi3 1Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Isra...
OBJECTIVE: To analyze and compare periodontal parameters in chronic renal failure (CRF) patients und...
Introduction. The effect of serum uric acid (SUA) concentration on residual urine volume in peritone...
to this paper. b Co-corresponding authors. ♦ Background: Endothelial dysfunction, which contributes...
.Objective:To determine the effect of peritoneal dialysis modalities such as nightly intermittent pe...
Background: There is a paucity of information on whether peritoneal dialysis (PD) slows the decline ...
Halitosis is a condition that affects 50% of adults and one third of patients with chronic kidney di...
Aim: To evaluate the oral conditions of patients with chronic kidney disease undergoing dialysis and...
The transport characteristics of the peritoneal membrane may be influenced by inflammation and vario...
Objective. The aim of this study was to investigate oral manifestations and salivary changes in pati...
Background and Aim: Halitosis, candidiasis, and metallic taste are some of the oral complications in...
Saliva plays a major role in preserving the integrity of oral tissues. The oral health of renal fail...
Background/Aims: The main purpose of the present study was to determine the effect of peritoneal cha...
This study aimed to determine the factors that were associated with hypoalbuminemia in peritoneal di...
Peritoneal dialysis (PD) is a well-established modality for treatment of patients with end-stage ren...